Ie. Bhorat et al., MALIGNANT VENTRICULAR ARRHYTHMIAS IN ECLAMPSIA - A COMPARISON OF LABETALOL WITH DIHYDRALAZINE, American journal of obstetrics and gynecology, 168(4), 1993, pp. 1292-1296
OBJECTIVE: Our aim was to assess the impact of beta-adrenergic blockad
e during the peripartum period on the previously observed high inciden
ce of ventricular arrhythmias in eclamptic parturients. STUDY DESIGN:
An open, randomized comparison of intravenous labetalol versus dihydra
lazine was conducted in 40 eclamptic subjects in the peripartum period
. Cardiac rhythm was assessed by blinded analysis of a 24-hour Hotter
record by means of the Lown classification of arrhythmias. RESULTS: Th
ere was a significantly higher incidence of serious ventricular arrhyt
hmias in patients receiving dihydralazine (81%) than in those receivin
g labetalol (17%, p < 0.0001). Patients receiving labetalol showed a s
ignificant decrease in mean heart rate (p < 0.0001), whereas patients
receiving dihydralazine showed a significant increase (p < 0.0001). CO
NCLUSION: The introduction of beta-adrenergic blockade into peripartum
hypertensive management of eclampsia significantly reduced the incide
nce of dangerous ventricular arrhythmias. Myocardial oxygen supply/dem
and ratio may be improved by beta-blockade.